The average EPS estimate for Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) for the three months ending 2016-12-31 is given as $0.32.
You find that 7 days ago, the average EPS estimate on the stock was $0.32, while for the 30 days ago the average EPS estimate stood at $0.32.
If you look back further, you see that the average EPS estimate for Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) 60 days ago was given as 0.32, while EPS estimate 90 days ago was quoted at $0.32.
The change in the stock’s EPS estimate over the last 7 days works out to 0%.
EPS estimate revisions
Over the last 7 days, EPS estimates for Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) have been revised up 0 times. In the same period, the EPS estimate has been revised down 0 times.
In the last 30 days, the stock has had its EPS estimate revised up 1 and it has been revised up 1 times over the last 60 days.
Up revisions in the last 90 days are 1 and up revisions in the last 120 days are 1.
But for the last 18 days, the company has seen its EPS revised up 0 times, offset by 0 down revisions in the same period.
The down revisions of EPS in last 30, 60, 90 and 120 days were 1, 1, 1 and 1.
What About EPS Surprises
Analysts predicted EPS of $0.32 for Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) for the period ended 2. But the company ended up posting actual EPS of $0.23 on 2016-08-03. The EPS estimate cited was worked out based on 2 estimates that analysts had issued on the stock.
Therefore, Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) posted EPS surprise of $0.02 per share in dollar terms, which works out to 9.52%. The standard deviation of the actual EPS reported by the company and the average EPS estimate immediately before the earnings were released works out to $0.01.
Quarterly Sales Estimates
For the fiscal year 2016, the mean and median annual sales estimates for the company are given as $57.11 and $55.7. The estimates are based on the projections of 3 analysts.
So far, the highest annual sales estimate for Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) stands at$60.73. That compares with the lowest annual sales estimate of $54.9. Calculating the standard deviation of the extreme annual sales estimates leads you to 3.16%.
Annual sales estimate adjustments
In the last 7 days, 3 analysts have raised their annual sales estimates for the company. But over the same period, 3 analysts have trimmed their annual sales estimates.
With that, you find that the percentage change in mean annual sales estimate in the last 7 days works out to -1.151%.
Over the last one month, though, 3 analysts moved to raise their sales estimates for Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP). That compares with 3 analysts who cut their sales estimate for the company in the same period. That leads you to -3.203% as the mean sales estimate change over the last one month.
If you look back further, you see that over the last three months, 3 analysts have moved raise their sales estimates Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP). That offset by 3 analysts who in the same period lowered their sales estimates for the stock. That works out to percentage change in mean sales estimate of -3.655% over a period of three months.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...